Juniper Pharma Signs Definitive Agreement to be Acquired by Catalent for $11.50 Per Share in Cash Read more
Pivotal and APRO partner to develop 3 investigator Sponsored Trials in Genitourinary Tumors Read more
Forendo Pharma Initiates Phase I Study for Potential New, Targeted Treatment for Endometriosis Read more
Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA (Tesamorelin for Injection) for FDA Approval Read more
Sanofi to further accelerate its scientific presence with the opening of a Global R&D Operations Hub in Chengdu, China Read more